Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-16

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for valsartan and hydrochlorothiazide (Valsartan/HCTZ) from Aurobindo Pharma Limited, authorizing an additional strength…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

SUPPL AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)